593 related articles for article (PubMed ID: 8567117)
1. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
3. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group.
Chang Y; Ziegler J; Wabinga H; Katangole-Mbidde E; Boshoff C; Schulz T; Whitby D; Maddalena D; Jaffe HW; Weiss RA; Moore PS
Arch Intern Med; 1996 Jan; 156(2):202-4. PubMed ID: 8546554
[TBL] [Abstract][Full Text] [Related]
5. Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS.
Wabinga HR; Parkin DM; Wabwire-Mangen F; Mugerwa JW
Int J Cancer; 1993 Apr; 54(1):26-36. PubMed ID: 8478145
[TBL] [Abstract][Full Text] [Related]
6. Geographical patterns of Kaposi's sarcoma, nonHodgkin lymphomas, and cervical cancer associated with HIV infection in five African populations.
Chaabna K; Boniol M; de Vuyst H; Vanhems P; Antônio de Ávila Vitoria M; Curado MP
Eur J Cancer Prev; 2012 Jan; 21(1):1-9. PubMed ID: 21955799
[TBL] [Abstract][Full Text] [Related]
7. Lympho-cutaneous Kaposi's sarcoma in an African pediatric AIDS case.
Bouquety JC; Siopathis MR; Ravisse PR; Lagarde N; Georges-Courbot MC; Georges AJ
Am J Trop Med Hyg; 1989 Mar; 40(3):323-5. PubMed ID: 2929857
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and associated risk factors for Kaposi's sarcoma among HIV-positive patients in a referral hospital in Northern Tanzania: a retrospective hospital-based study.
Semango GP; Charles RM; Swai CI; Mremi A; Amsi P; Sonda T; Shao ER; Mavura DR; Joosten LAB; Sauli E; Nyindo M
BMC Cancer; 2018 Dec; 18(1):1258. PubMed ID: 30558571
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Simpson GR; Schulz TF; Whitby D; Cook PM; Boshoff C; Rainbow L; Howard MR; Gao SJ; Bohenzky RA; Simmonds P; Lee C; de Ruiter A; Hatzakis A; Tedder RS; Weller IV; Weiss RA; Moore PS
Lancet; 1996 Oct; 348(9035):1133-8. PubMed ID: 8888167
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma in South Africa.
Sitas F; Newton R
J Natl Cancer Inst Monogr; 2001; (28):1-4. PubMed ID: 11158199
[TBL] [Abstract][Full Text] [Related]
11. Influence of HIV epidemic on the incidence of Kaposi's sarcoma in Zambian children.
Athale UH; Patil PS; Chintu C; Elem B
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):96-100. PubMed ID: 8548353
[TBL] [Abstract][Full Text] [Related]
12. EPHA2 sequence variants are associated with susceptibility to Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma prevalence in HIV-infected patients.
Blumenthal MJ; Schutz C; Meintjes G; Mohamed Z; Mendelson M; Ambler JM; Whitby D; Mackelprang RD; Carse S; Katz AA; Schäfer G
Cancer Epidemiol; 2018 Oct; 56():133-139. PubMed ID: 30176543
[TBL] [Abstract][Full Text] [Related]
13. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
[TBL] [Abstract][Full Text] [Related]
15. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children.
Kalyesubula I; Musoke-Mudido P; Marum L; Bagenda D; Aceng E; Ndugwa C; Olness K
Pediatr Infect Dis J; 1997 Sep; 16(9):876-81. PubMed ID: 9306483
[TBL] [Abstract][Full Text] [Related]
16. Variants of Kaposi's sarcoma in Southern Africa. A retrospective analysis (1980-1992).
Stein ME; Lachter J; Spencer D; Margolius L; Bezwoda WR
Acta Oncol; 1996; 35(2):193-9. PubMed ID: 8639315
[TBL] [Abstract][Full Text] [Related]
17. Robbing the cradle.
Toomey G
IDRC Rep; 1989 Apr; 18(2):10. PubMed ID: 12342722
[TBL] [Abstract][Full Text] [Related]
18. Antibody to the AIDS virus in Kaposi's sarcoma in Nigeria.
Otu AA
J Surg Oncol; 1988 Mar; 37(3):152-5. PubMed ID: 3162540
[TBL] [Abstract][Full Text] [Related]
19. The epidemiology of classic, African, and immunosuppressed Kaposi's sarcoma.
Wahman A; Melnick SL; Rhame FS; Potter JD
Epidemiol Rev; 1991; 13():178-99. PubMed ID: 1765111
[TBL] [Abstract][Full Text] [Related]
20. Recent developments in sexually transmitted diseases: is Kaposi's sarcoma a sexually transmitted disease?
Felman YM
Cutis; 1990 Oct; 46(4):303-6. PubMed ID: 2261787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
